Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AdAlta Ltd. (AU:1AD)
ASX:1AD
Holding AU:1AD?
Track your performance easily
1AD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
Volume270.05K
Average Volume (3M)131.93K
Market Cap
AU$10.73M
Enterprise ValueAU$12.98M
Total Cash (Recent Filing)$5.56M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta<0.01
Next Earnings
Mar 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding631,458,070
10 Day Avg. Volume97,491
30 Day Avg. Volume131,933
Standard Deviation0.16
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.29
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit13.14
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AdAlta Ltd. News
PremiumCompany Announcements
AdAlta Ltd. Issues Performance Rights to Boost Talent Retention
PremiumCompany Announcements
AdAlta to Present at Biotech Showcase 2025 During JPMorgan Healthcare Week
PremiumCompany Announcements
AdAlta Ltd. Prepares to Showcase Breakthrough Therapies
PremiumCompany Announcements
AdAlta Ltd. Showcases Drug Development Prospects
PremiumCompany Announcements
AdAlta Limited Gains Strong Support in AGM
PremiumCompany Announcements
AdAlta Limited Advances Drug Discovery and PartnershipsPremiumCompany Announcements
AdAlta Strengthens Board with New Appointments
PremiumCompany Announcements
AdAlta Ltd. Sees Shift in Major ShareholdingOptions Prices
Currently, No data available
---
Ownership Overview
1AD FAQ
What was AdAlta Ltd.’s price range in the past 12 months?
AdAlta Ltd. lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is AdAlta Ltd.’s market cap?
AdAlta Ltd.’s market cap is AU$10.73M.
When is AdAlta Ltd.’s upcoming earnings report date?
AdAlta Ltd.’s upcoming earnings report date is Mar 03, 2025 which is in 43 days.
How were AdAlta Ltd.’s earnings last quarter?
AdAlta Ltd. released its earnings results on Aug 28, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is AdAlta Ltd. overvalued?
According to Wall Street analysts AdAlta Ltd.’s price is currently Overvalued.
Does AdAlta Ltd. pay dividends?
AdAlta Ltd. does not currently pay dividends.
What is AdAlta Ltd.’s EPS estimate?
AdAlta Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AdAlta Ltd. have?
AdAlta Ltd. has 631,458,070 shares outstanding.
What happened to AdAlta Ltd.’s price movement after its last earnings report?
AdAlta Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AdAlta Ltd.?
Currently, no hedge funds are holding shares in AU:1AD
---
AdAlta Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:1AD Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.16%
12-Months-Change
Fundamentals
Return on Equity
-273.13%
Trailing 12-Months
Asset Growth
-27.93%
Trailing 12-Months
Company Description
AdAlta Ltd.
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal.
---
Technical Analysis
Australian Clinical Labs Ltd
―
Atomo Diagnostics Ltd.
―
Recce Pharmaceuticals Ltd.
―
Race Oncology Ltd.
―
---